A Clinical Study of LCB01-0371

NCT ID: NCT02836483


Title
A Prospective, Randomized, Open, Active-controlled, Interventional, Exploratory, Phase II Trial to Evaluate the EBA, Safety and PK of Orally Administered LCB01-0371 in Adult Patients
Purpose
A Prospective, Randomized, Open, Active-controlled, Interventional, Exploratory, Phase II Trial of LCB01-0371.
Details
This study is designed to explore antituberculosis of LCB01-0371 through the assess of the early bactericidal activity, safety of administration.
Conditions
Pulmonary Tuberculosis
Keywords
Source
LegoChem Biosciences, Inc
Sponsors
LegoChem Biosciences, Inc
Status
Not yet recruiting
Acronym
Last Updated
17 Jul 2016
URL
Official Link
Locations